{"id":2157,"date":"2008-02-01T12:07:00","date_gmt":"2008-02-01T11:07:00","guid":{"rendered":"https:\/\/der-arzneimittelbrief.com\/artikel\/2008\/boxed-warning-fuer-i-v-ultraschall-kontrastmittel"},"modified":"2008-02-01T12:07:00","modified_gmt":"2008-02-01T11:07:00","slug":"boxed-warning-fuer-i-v-ultraschall-kontrastmittel","status":"publish","type":"post","link":"https:\/\/der-arzneimittelbrief.com\/artikel\/2008\/boxed-warning-fuer-i-v-ultraschall-kontrastmittel","title":{"rendered":"\u201eBoxed Warning\u201d f\u00fcr i.v. Ultraschall-Kontrastmittel"},"content":{"rendered":"<p>Nach den gadoliniumhaltigen i.v. Kontrastmitteln f\u00fcr die Magnetresonanztomographie (1) haben nun auch i.v. Kontrastmittel f\u00fcr Ultraschalltechniken eine Warnung der US Food and Drug Administration erhalten. Der am 17. Oktober 2007 ver\u00f6ffentlichte \u201eFDA Alert\u201d berichtet \u00fcber eine Erg\u00e4nzung der Gebrauchsinformationen der Kontrastmittel (KM) Definity\u00ae und Optison\u00ae durch einen umrahmten Warnhinweis (\u201eBoxed Warning\u201d) wegen schwerer kardiopulmonaler UAW [&hellip;]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Nach den gadoliniumhaltigen i.v. Kontrastmitteln f\u00fcr die Magnetresonanztomographie (1) haben nun auch i.v. Kontrastmittel f\u00fcr Ultraschalltechniken eine Warnung der US Food and Drug Administration erhalten. Der am 17. Oktober 2007 ver\u00f6ffentlichte \u201eFDA Alert\u201d berichtet \u00fcber eine Erg\u00e4nzung der Gebrauchsinformationen der Kontrastmittel (KM) Definity\u00ae und Optison\u00ae durch einen umrahmten Warnhinweis (\u201eBoxed Warning\u201d) wegen schwerer kardiopulmonaler UAW [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[4343,4344,3839,4342],"class_list":["post-2157","post","type-post","status-publish","format-standard","hentry","category-allgemein","tag-levovist","tag-luminity","tag-optison","tag-ultraschall-kontrastmittel"],"_links":{"self":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/2157","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/comments?post=2157"}],"version-history":[{"count":0,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/2157\/revisions"}],"wp:attachment":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/media?parent=2157"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/categories?post=2157"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/tags?post=2157"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}